T1	Participants 92 170	599 evaluable patients with benign prostatic hypertrophy at 7 urological units
T2	Participants 251 442	group 1--197 patients given single-dose ceftriaxone (2 gm.), group 2--203 patients given 160/800 mg. trimethoprimsulfamethoxazole and group 3--199 controls given no antimicrobial prophylaxis.
T3	Participants 443 592	Patients with a preoperative indwelling catheter, positive urine culture, signs of active infection or preoperative antibiotic treatment were exclude
